Literature DB >> 22016028

Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension.

Yeun Ying Wong1, Nico Westerhof, Gerrina Ruiter, Mark Lubberink, Pieter Raijmakers, Paul Knaapen, J Tim Marcus, Anco Boonstra, Adriaan A Lammertsma, Willem J van der Laarse, Anton Vonk-Noordegraaf.   

Abstract

AIMS: Increased afterload in idiopathic pulmonary arterial hypertension (IPAH) causes right ventricular (RV) hypertrophy and failure. Since RV remodelling occurs with alterations in RV oxygen metabolism, increasing our understanding in the factors determining RV O(2) consumption in IPAH is necessary. In the left ventricle, it is known that heart rate and systolic blood pressure are the main determinants of myocardial O(2) consumption (MVO(2)). However, the normal right heart has lower oxygen extraction and perfusion than the left myocardium, and RV energy metabolism is changed in hypertrophy. Therefore, it is not obvious that the relationsships of pressure and heart rate to MVO(2) hold for the overloaded human right heart. We hypothesize that systolic pulmonary artery pressure (PAP) and heart rate (HR) are the major determinants of RV MVO(2) in IPAH. METHODS AND
RESULTS: In 18 IPAH patients (New York Heart Association class II and III), RV MVO(2) was determined using positron emission tomography and (15)O tracers. PAP and HR were measured during right heart catheterization. RV MVO(2) was found to be related to systolic PAP (R(2) = 0.54, P < 0.001), and inversely to stroke volume (R(2) = 0.32, P = 0.015) and HR (R(2) = 0.32, P = 0.014). Relationships of MVO(2) to the rate pressure product (RPP), i.e. systolic pressure × HR, and wall stress were R(2) = 0.55, P < 0.001, and R(2) = 0.30, P = 0.020, respectively. Multiple regression of MVO(2) on HR and systolic PAP gave R(2) = 0.59, P = 0.001.
CONCLUSION: Systolic PAP and HR are the major determinants of RV MVO(2) in IPAH. A further increase of HR and PAP with IPAH progression suggests a compromised RV myocardial oxygen availability.

Entities:  

Mesh:

Year:  2011        PMID: 22016028     DOI: 10.1093/eurjhf/hfr140

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  14 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

2.  The effects of asymmetric ventricular filling on left-right ventricular interaction in the normal rat heart.

Authors:  Kimberley Pett; David Hauton
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

3.  Attenuated right ventricular energetics evaluated using ¹¹C-acetate PET in patients with pulmonary hypertension.

Authors:  Keiichiro Yoshinaga; Hiroshi Ohira; Ichizo Tsujino; Noriko Oyama-Manabe; Lisa Mielniczuk; Rob S B Beanlands; Chietsugu Katoh; Katsuhiko Kasai; Osamu Manabe; Takahiro Sato; Satoshi Fujii; Yoichi M Ito; Yuuki Tomiyama; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

4.  Right ventricular myocardial energetic model for evaluating right heart function in pulmonary arterial hypertension.

Authors:  Jacqueline V Scott; Tanuf U Tembulkar; Meng-Lin Lee; Bradley T Faliks; Kelly L Koch; Anton Vonk-Noordegraaf; Keith E Cook
Journal:  Physiol Rep       Date:  2022-05

Review 5.  State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series).

Authors:  Mariëlle C van de Veerdonk; J Tim Marcus; Harm-Jan Bogaard; Anton Vonk Noordegraaf
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

6.  Increased myocardial oxygen consumption rates are associated with maladaptive right ventricular remodeling and decreased event-free survival in heart failure patients.

Authors:  Ali Ahmadi; Jennifer M Renaud; Steven Promislow; Ian G Burwash; Girish Dwivedi; Ran Klein; Jason G E Zelt; Robert A deKemp; Rob S Beanlands; Lisa M Mielniczuk
Journal:  J Nucl Cardiol       Date:  2020-05-07       Impact factor: 5.952

Review 7.  Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma.

Authors:  Hendrik J Harms; Mariëlle C van de Veerdonk; Adriaan A Lammertsma; Anton Vonk Noordegraaf; Harm Jan Bogaard
Journal:  Transl Respir Med       Date:  2013-12-11

Review 8.  Treatment strategies for the right heart in pulmonary hypertension.

Authors:  Berend E Westerhof; Nabil Saouti; Willem J van der Laarse; Nico Westerhof; Anton Vonk Noordegraaf
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

9.  Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Emmanouil Tampakakis; Sanjiv J Shah; Barry A Borlaug; Peter J Leary; Harnish H Patel; Wayne L Miller; Benjamin W Kelemen; Brian A Houston; Todd M Kolb; Rachel Damico; Stephen C Mathai; Edward K Kasper; Paul M Hassoun; David A Kass; Ryan J Tedford
Journal:  Circ Heart Fail       Date:  2018-04       Impact factor: 8.790

10.  Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.

Authors:  Daniel Morales-Cano; Maria Callejo; Bianca Barreira; Gema Mondejar-Parreño; Sergio Esquivel-Ruiz; Sonia Ramos; María Ángeles Martín; Angel Cogolludo; Laura Moreno; Francisco Perez-Vizcaino
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.